5-(4-((2S,5S)-5-(4-CHLOROBENZYL)-2-METHYLMORPHOLINO)PIPERIDIN-1-YL)-1H-1,2,4-TRIAZOL-3-AMINE
UNII X4D0G881CN
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-(4-((2s,5s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1h-1,2,4-triazol-3-amine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X4D0G881CN.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2088453-21-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H27ClN6O STWVLEKJQQRGMO-GUYCJALGSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-(4-((2s,5s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1h-1,2,4-triazol-3-amine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.